We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$484M
AUM Growth
-$37.2M
Cap. Flow
-$56.6M
Cap. Flow %
-11.7%
Top 10 Hldgs %
14.7%
Holding
763
New
237
Increased
113
Reduced
133
Closed
279

Top Buys

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$17.9M
2
TGT icon
Target
TGT
+$7.23M
3
ORCL icon
Oracle
ORCL
+$5.76M
4
HON icon
Honeywell
HON
+$5.03M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$4.61M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$7.8M
2
BABA icon
Alibaba
BABA
+$7.75M
3
MU icon
Micron Technology
MU
+$7.71M
4
PG icon
Procter & Gamble
PG
+$6.56M
5
NFLX icon
Netflix
NFLX
+$4.88M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Consumer Discretionary 15.91%
3 Healthcare 12.96%
4 Industrials 11.61%
5 Consumer Staples 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMX icon
601
CarMax
KMX
$8.49B
-24,200
Closed -$1.69M
KN icon
602
Knowles
KN
$2.97B
-22,550
Closed -$398K
KRE icon
603
State Street SPDR S&P Regional Banking ETF
KRE
$4.31B
-19,700
Closed -$1.01M
LAB icon
604
Standard BioTools
LAB
$271M
-25,870
Closed -$344K
LAD icon
605
Lithia Motors
LAD
$7.6B
-2,217
Closed -$206K
LGND icon
606
Ligand Pharmaceuticals
LGND
$5.52B
-6,115
Closed -$480K
LH icon
607
Labcorp
LH
$26.3B
-2,910
Closed -$382K
LNC icon
608
Lincoln National
LNC
$8.32B
-5,538
Closed -$325K
LNTH icon
609
Lantheus
LNTH
$6.58B
-10,758
Closed -$263K
LYB icon
610
LyondellBasell Industries
LYB
$21.1B
-6,000
Closed -$504K
MAS icon
611
Masco
MAS
$13.6B
-12,300
Closed -$484K
MCD icon
612
McDonald's
MCD
$179B
-11,529
Closed -$2.19M
MCHP icon
613
Microchip Technology
MCHP
$38.8B
-46,348
Closed -$1.92M
MFC icon
614
Manulife Financial
MFC
$72.7B
-24,000
Closed -$406K
MGNI icon
615
Magnite
MGNI
$3.4B
-26,800
Closed -$163K
MGNX icon
616
MacroGenics
MGNX
$257M
-10,384
Closed -$187K
MGPI icon
617
MGP Ingredients
MGPI
$308M
-6,013
Closed -$464K
MKC icon
618
McCormick & Company Non-Voting
MKC
$13.4B
-63,964
Closed -$4.82M
MRSH
619
Marsh
MRSH
$85.8B
-2,900
Closed -$272K
MMSI icon
620
Merit Medical Systems
MMSI
$5.15B
-4,696
Closed -$290K
MOG.A icon
621
Moog Inc Class A
MOG.A
$11.3B
-2,440
Closed -$212K
MOH icon
622
Molina Healthcare
MOH
$10.8B
-5,572
Closed -$791K
MOS icon
623
The Mosaic Company
MOS
$8.09B
-44,900
Closed -$1.23M
MRVL icon
624
Marvell Technology
MRVL
$199B
-12,000
Closed -$239K
MS icon
625
Morgan Stanley
MS
$324B
-14,600
Closed -$616K

Similar funds

Bayesian Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Bayesian Capital Management held 763 positions worth $484M, down 7.1% from $521M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Bayesian Capital Management withdrew a net $56.6M in Q2 2019, closing 279 positions and reducing 133 holdings. Its most notable exit was Accenture, an estimated $7.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Walgreens Boots Alliance worth $18.4M.

  • Bayesian Capital Management's largest Q2 2019 buy was Walgreens Boots Alliance: 336,390 shares worth $18.4M.
  • Bayesian Capital Management added most to Honeywell in Q2 2019, an estimated $5.03M increase.
  • Bayesian Capital Management's biggest Q2 2019 reduction was Foot Locker, cutting an estimated $4.82M.
  • Bayesian Capital Management fully exited Accenture in Q2 2019, selling an estimated $7.8M.
  • Bayesian Capital Management's ten largest holdings make up 15% of its $484M portfolio in Q2 2019.
  • Bayesian Capital Management opened 237 new positions and closed 279 in Q2 2019.
  • Bayesian Capital Management's portfolio value fell 7.1% quarter-over-quarter to $484M.

Based on Bayesian Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.